Latest
-
Precision Cancer Medicines for Colon Cancer
Genomic testing identifies genetic targets that can be treated with precision cancer medicines avoiding chemotherapy
-
New First‑Line Option for Advanced Triple‑Negative Breast Cancer: Trodelvy Approved Alone and With Keytruda
The FDA has approved sacituzumab govitecan (Trodelvy) both by itself and in combination with pembrolizumab (Keytruda) as a first treatment for certain adults with advanced triple negative breast cancer, offering a new way to control the disease longer than standard chemotherapy.
Welcome to CancerConnect
CancerConnect is a unique resource that brings patients, caregivers, advocates and experts together – individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, and treatment and the support of other individuals being treated at some of the best cancer centers. CancerConnect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey. Search the over 7000 articles on the management of cancer.
